Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 6, 1997, Pages 395-405

  Reddy, D S ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

4' Chlordiazepam; Allopregnanolone; Anxiety; BZD tolerance and withdrawal; Dehydroepiandrosterone sulfate; Diazepam; Motor activity; Neurosteroids; Pregnenolone sulfate; Progesterone; Triazolam

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROSTEROID; PRASTERONE SULFATE; TETRAHYDRODEOXYCORTICOSTERONE; TRIAZOLAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; HYPERACTIVITY; LIGAND BINDING; MOUSE; NONHUMAN; SEDATION; STEROIDOGENESIS; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

ANIMALS; ANXIETY; BENZODIAZEPINONES; CONVULSANTS; DIAZEPAM; DRUG COMBINATIONS; DRUG TOLERANCE; GABA MODULATORS; MALE; MICE; MOTOR ACTIVITY; PROGESTERONE; SUBSTANCE WITHDRAWAL SYNDROME; TRIAZOLAM;

EID: 0030782071     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Akwa, Y., Young, J., Kabbadj, K. et al. Neurosteroids: Biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J Steroid Biochem Mol Biol 1991, 40: 71-81.
2. Paul, S.V., Purdy, R.H. Neuroactive steroids. FASEB J 1992, 6: 2311-22.
3. Kulkarni, S.K., Reddy, D.S. Neurosteroids: A new class of neuromodulators. Drugs Today 1995, 31: 433-55.
4. Robel, P., Baulieu, E.E. Neurosteroids: Biosynthesis and function. Trends Endocrinol Metab 1994, 5: 1-8.
5. Costa, E., Guidotti, A. Diazepam binding inhibitor (DBI): A peptide with multiple biological actions. Life Sci 1991, 49: 325-44.
6. Korneyev, A., Pan, B.S., Polo, A., Romeo, E., Guidotti, A., Costa, E. Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J Neurochem 1993, 61: 1515-24.
7. Guarneri, P., Papadopoulos, V., Pan, P., Costa, E. Regulation of pregnenolone synthesis in C6-2B glioma cells by 4'-chlordiazepam. Proc Natl Acad Sci USA 1992, 89: 5118-22.
8. Auta, J., Romeo, A., Kozikowski, A., Ma, D., Costa, E., Guidotti, A. Participation of mitochondrial diazepam binding inhibitor receptor in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J Pharmacol Exp Ther 1993, 265: 649-56.
9. A-A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992, 38: 379-96.
10. A receptor function. Trends Pharmacol Sci 1995, 16: 295-303.
11. Wu, F-S., Gibbs, T.T., Farb, D.H. Inverse modulation of γ-aminobutyric acid and glycine-induced currents by progesterone. Mol Pharmacol 1990, 37: 597-602.
12. Ffrench-Mullen, J.M.H., Danks, P., Spence, K.T. Neurosteroids modulate calcium currents in hippocampal CAI neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J Neurosci 1994, 14: 1963-77.
13. Wu, F-S., Gibbs, T.T., Farb, D.H. Pregnenolone sulfate: A positive allosteric modulator at the NMDA receptor. Mol Pharmacol 1991, 40: 333-6.
14. Irwin, R.P., Maragakis, N.J., Rogawski, M.A., Purdy, R.H., Farb, D.H., Paul, S.M. Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular calcium in cultured rat hippocampal neurons. Neurosci Lett 1994, 141: 30-4.
15. Spence, K.T., Plata-Salaman, C.R., Ffrench-Mullen, J.M.H. The neurosteroids pregnenolone and pregnenolone-sulfate but not progesterone, block calcium currents in acutely isolated hippocampal CAI neurons. Life Sci 1991, 49: PL235-9.
16. 2-agonists of diazepam withdrawal hyperactivity in rats. Psychopharmacology 1986, 90: 198-202.
17. Woods, J.H., Katz, J.L., Winger, G. Benzodiazepines: Use, abuse and consequences. Pharmacol Rev 1992, 44: 151-347.
18. Woods, J.H., Winger, G. Current benzodiazepine issues. Psychopharmacology 1995, 118-5.
19. Woods, J.H., Katz, J.L., Winger, G. Abuse liability of benzodiazepines. Pharmacol Rev 1990, 39: 251-419.
20. Miller, L.G., Greenblatt, D.J., Barnhill, J.G., Shader, R.I. Chronic benzodiazepine administration.I. Tolerance is associated with decreased benzodiazepine receptor down-regulation and decreased gamma-aminobutyric acid A receptor function. J Pharmacol Exp Ther 1988, 246: 170-6.
21. A and mitochondrial diazepam binding inhibitor (MDR) receptors in the antistress activity of neurosteroids in mice. Psychopharmacology 1996, 128: 280-92.
22. Reddy, D.S., Kulkarni, S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 1997, 752: 61-71.
23. Lister, R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92: 180-5.
24. Kulkarni, S.K., Reddy, D.S. Animal behavioral models for testing anti-anxiety agents. Meth Find Exp Clin Pharmacol 1996, 18: 219-30.
25. Jumg-Testas, I., Hu, Z.Y., Baulieu, E.E., Robel, P. Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 1989, 125: 2083-91.
26. Steppuhn, K.G., Turski, L. Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci USA 1993, 90: 6889-93.
27. Andrews, N., File, S.E. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioral evidence. Psychopharmacology 1993, 112: 21-5.
28. Martigena, I.D., Tupia, M., Molina, V.A. Altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats. Brain Res 1996, 712: 239-44.
29. A receptor complex: The pharmacological properties and therapeutic potentials of epalons. Crit Rev Neurobiol 1995, 9: 207-27.
30. A/benzodiazepine receptor complex in mammalian cortical neurons. Mol Pharmacol 1995, 47: 603-10.
31. +-induced GABA and glutamate release from identified nerve terminals in rat hippocampus: A semiquantitative immunocytochemical study. Brain Res 1993, 623, 329-33.
32. Rupprecht, R., Hauser C.A.E., Trapp, T., Holsboer, F. Neurosteroids - Molecular mechanisms of action and psychopharmacological significance. J Steroid Biochem Mol Biol 1996, 56: 163-8.
33. Schumacher, M., Robel, P., Baulieu, E-E. Development and regeneration of the nervous system - A role for neurosteroids. Dev Neurosci 1996, 18: 6-21.
34. Belelli, D., Bolger, M.B., Gee, K.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol 1989, 166: 325-9.
35. Frye, C.A. The neurosteroid 3α-5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995, 696: 113-20.
36. A receptor complex. J Pharmacol Exp Ther 1987 241: 346-53.
37. Freeman, E.W., Purely, R. H., Coutitaris, C., Rickels, K., Paul, S.M. Anxiolytic metabolites of progesterone: Correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 1993, 58: 478-84.
38. A receptor. Proc Natl Aead Sci USA 1995, 92: 3769-73.
39. A receptor function observed in progesterone-treated ovariectomized rats. Soc Neurosci Abstr 1993, 19: 373-83.
40. A receptor function. Pharmacol Biochem Behav 1993, 45: 423-8.
41. Picazo, O., Fernandez-Guasti, A. Anti-anxiety effects of progesterone and some of its reduced metabolites: An evaluation using the burying behavior test. Brain Res 1995, 680: 135-41.
42. Smith, S.S. The effects of estrogen and progesterone on GABA and glutamate responses at extrahypothalamic sites. In: Neurosleroids and Brain Function. Fidia Research Foundation Symposium Series, Vol. 8. E. Costa and S.M. Paul (Eds.). Thieme Medical Publishers: New York 1991, 87-94.
43. Mok, W.M. Krieger, N.R. Evidence that 5α-pregnan-3α-hydroxy-20-one is the metabolites responsible for anesthesia induced by 5α-pregnanedione in the mouse. Neurosci Lett 1990, 135: 145-8.
44. Maggi, A., Perez, J. Progesterone and estrogens in rat brain: Modulation of GABA receptor activity. Eur J Pharmacol 1984, 103: 165-8.
45. Schwerzer, E., Case, W.W., Garcia-Espana, F., Greenblatt, D.J., Rickels, K. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy effects on withdrawal severity and taper outcome. Psychopharmacology 1995, 117: 424-9.
46. Papadopoulos, V., Guarneri, P., Krueger, K.E., Guidotti, A., Costa, E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: Regulation by mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci USA 1992, 89: 5113-7.
47. Ffrench-Mullen, J.M.H. Cortisol inhibition of calcium currents in guinea pig hippocampal CAI neurons via G-protein-coupled activation of protein kinase C. J Neurosci 1995, 15: 303-11.
48. Ffrench-Mullen, J.M.H., Spence, K.T. Neurosteroids block calcium channel current in freshly isolated hippocampal CAI neurons. Eur J Pharmacol 1991, 202: 269-72.